Business Daily Media

Men's Weekly

.

Australian Medicinal Cannabis


New Medical Cannabis Growing Facility Opens in Brisbane

Australian Natural Therapeutics Group (ANTG), one of the largest growers and producers of medicinal cannabis in the country, has acquired a licensed cultivation and pharmaceutical manufacturing facility in Brisbane. 

 

The commercial-scale operation, expected to quadruple production capacity, enables the entire range of ANTG’s cultivars to become available to patients in new formats such as extracts, soluble, and pastilles. 

 

“It’s a welcome development for both patients and doctors as we introduce additional dosage formats and ultimately more therapeutic pathways in the patient journey” says Australian Natural Therapeutics Group CEO and founder Matt Cantelo. 

 

The new facility, housing multiple indoor cultivation rooms and fourteen GMP (Good Manufacturing Practice) areas, allows ANTG to enhance its specialised genetic breeding program and bolster its flower production capacity. 

And in a boost for the domestic medicinal cannabis industry, the Brisbane facility will provide broader Australian industry utilisation in outsourced manufacturing.  

 

“Up until now our focus has been largely on cultivation. This facility enables us to alleviate industry bottlenecks by increasing our manufacturing capacity, resulting in more Australian product,” says Cantelo. 

 

Medicinal cannabis is now used by tens of thousands of Australians, with latest data from the Therapeutic Goods Administration (TGA) showing that more than 110,000 medicinal cannabis approvals were issued this year alone. 

 

New research from the University of Sydney's Lambert Initiative also found that while many Australians are still medicating with illicit cannabis, the number of people accessing prescription products has risen dramatically. 

 

The survey found 37 percent of respondents had received a legal prescription for medicinal cannabis – a significant increase from the 2.5 percent of respondents reporting prescription use in the 2018 iteration of the CAMS survey. 

 

*https://freshleafanalytics.com.au/wp-content/uploads/2021/10/FreshLeaf-Analytics-H2-2021.pdf 

 

About Australian Natural Therapeutics Group 

 

Formed in 2015, ANTG is a leader in the cultivation and advancement of medicinal cannabis research in Australia. The company was granted one of the first licenses to produce large quantities of medicinal cannabis oil for commercial use, meeting GMP (Good Manufacturing Practice) and GACP (Good Agricultural Collection Practice) standards. It also partners with research organisations including the University of Newcastle and Western Sydney University, to unlock the therapeutic potential for medicinal cannabis patients.  https://antg.com.au/ 

Minns Labor Government shutting down the Business Connect program

The NSW Opposition is concerned that the Labor government will shut down a support program that has assisted New South Wales businesses. In a media ...

Samsara Eco appoints Dr. Lars Kissau as General Manager for Asia

Australian biotech innovator Samsara Eco has announced the appointment of Dr Lars Kissau as its first General Manager of Asia. Based in Singapore...

From the first bounce to the final siren - small business lessons from the AFL Grand Final

The AFL Grand Final is one of the most anticipated days on the sporting calendar. This Saturday, the Geelong Cats and Brisbane Lions will battle i...

Australia’s top finance leaders recognised as CFO role expands

Amid surging regulatory demands and rapidly evolving industry, Australia’s most influential Chief Financial Officers will be honoured at the inaug...

Why outdated security leaves small businesses exposed to crime

Small and medium businesses in Australia are under increasing pressure to address security gaps that criminals readily exploit. An unlocked door, an...

Why it’s time telcos rethink location and put customer experience first

Maurice Zicman, Vice President - CX Strategy at TP in Australia unpacks why the telco industry must rethink old assumptions and focus on digital-f...